Ginkgo Bioworks (DNA) Misses Q1 EPS by 2c

Ginkgo Bioworks (NYSE: DNA) reported Q1 EPS of ($0.11), $0.02 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $80.7 million versus the consensus estimate of $70.75 million.

For earnings history and earnings-related data on Ginkgo Bioworks (DNA) click here.

You May Also Be Interested In

• SanDisk and Micron surge as Apple confirms memory price pass-through
• Air France-KLM (AF:FP) (AFLYY) PT Raised to EUR13.50 at UBS
• Vail Resorts taps bankers for potential activist defense, Semafor reports